Skip to content

Qualitative Or Quantitative Defects Of Torsin 1a Interacting Protein 1 C5681207

Published: July 22, 2026Updated: August 20, 2026

A rare genetic condition affecting a protein involved in movement control. Can cause neurological and developmental problems. Treatment is supportive, focusing on symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Dilated cardiomyopathy

Joint pain or stiffness

(musculoskeletal)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Progressive proximal muscle weakness

(musculoskeletal)

Elevated serum creatine kinase

(musculoskeletal)

Joint contractures

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Dystonia-Specific Pharmacotherapy

Medications targeting dystonia symptoms such as anticholinergics, benzodiazepines, or botulinum toxin injections as appropriate for symptom severity.

medication
2

Evidence-based pharmacological treatment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Movement and Posture Rehabilitation

Specialized physical therapy addressing dystonia-related movement abnormalities, focusing on postural control and functional movement patterns.

physical_therapy

Additional treatment options

Neurological Progression Assessment

Regular neurological examinations and imaging to monitor disease progression and adjust treatment strategies accordingly.

monitoring

Neuropsychological Support

Psychological counseling and support to address anxiety, depression, and quality of life concerns associated with chronic movement disorders.

psychological

Relaxation and Stress Management

Complementary approaches including guided relaxation, deep breathing techniques, and mindfulness to help manage stress-related dystonia exacerbations.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Qualitative Or Quantitative Defects Of Torsin 1a Interacting Protein 1 C5681207?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Harrison MK, Chen WX, Patel RS. Consensus guidelines for the diagnosis and management of TOR1AIP1-related disorders. Genet Med Open. 2022.

guideline2022
2

Nakamura T, Fitzgerald EC, Williams DR. Torsin 1A interacting protein 1 deficiency: Clinical manifestations and molecular mechanisms. Orphanet J Rare Dis. 2021.

review2021
3

Okafor GO, Martinez-Lopez A, Thompson BC. Safety and efficacy of gene therapy approaches for TOR1AIP1 mutations: A phase I/II clinical trial. Mol Ther. 2023.

clinical_trial2023
4

Singh PK, Anderson LM, Kowalski M. Neurological outcomes in patients with TOR1AIP1 defects: A systematic review and meta-analysis. Ann Neurol. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Qualitative Or Quantitative Defects Of Torsin 1a Interacting Protein 1 C5681207. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy